Vimarsana
Biggest News Aggregation in the World

Roche Diagnostics Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Diagnostics Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Diagnostics Communications Today - Breaking & Trending Today

Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab - Vimarsana News

Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will be showcasing innovative laboratory solutions and digital diagnostics through -...

Roche Molecular Systems, Inc.: Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab - Vimarsana News

Roche Molecular Systems, Inc.: Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab

Roche will unveil the next generation of its serum work area, several molecular systems and the cobas® connection module. The company will introduce navify® digital solutions that help laboratories

Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo - Vimarsana News

Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the VENTANA PD-L1 (SP263)...

Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics - Vimarsana News

Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create...

Roche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE - Vimarsana News

Roche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay,...